Evidence map›Paper›PMID 34039996›Full record

ArticleNature communications2021

Architecture of the Sema3A/PlexinA4/Neuropilin tripartite complex.

Defen Lu, Guijun Shang, Xiaojing He, Xiao-Chen Bai, Xuewu Zhang

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. [Construction of a highly efficient HBV infection cell model based on HBV co-receptor neuropilin-1].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Molecular mechanisms of proteoglycan-mediated semaphorin signaling in axon guidance.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Role of Semaphorin 3A in Kidney Development and Diseases.Diagnostics (Basel, Switzerland) · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Defen Lu *Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Guijun Shang *Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Xiaojing He *Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
Xiao-Chen BaiDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USA. xiaochen.bai@utsouthwestern.edu.ORCID http://orcid.org/0000-0002-4234-5686
Xuewu ZhangDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Xuewu.zhang@utsouthwestern.edu.ORCID http://orcid.org/0000-0002-3634-6711
Southwestern Medical Center · USThe University of Texas Southwestern Medical Center · USHuazhong University of Science and Technology · CN

Funding

Transmembrane signaling mechanisms of plexin - SupplementR35GM130289 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI Xuewu Zhang · 2019 to 2026
$3.6M
Structural and Functional Analyses of the Full-length Insulin Receptor (IR) and Type 1 Insulin-like Growth Factor Receptor (IGF1R) in the Liganded Active StateR01GM136976 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI BAI, XIAOCHEN · 2020 to 2024
$1.8M
Structural insights into the unique activation mechanisms of receptor tyrosine kinasesR01GM143158 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI BAI, XIAOCHEN · 2021 to 2024
$1.6M
NIGMS NIH HHS R01 GM136976NIGMS NIH HHS R35 GM130289
6 · The paper itself

Abstract

Secreted class 3 semaphorins (Sema3s) form tripartite complexes with the plexin receptor and neuropilin coreceptor, which are both transmembrane proteins that together mediate semaphorin signal for neuronal axon guidance and other processes. Despite extensive investigations, the overall architecture of and the molecular interactions in the Sema3/plexin/neuropilin complex are incompletely understood. Here we present the cryo-EM structure of a near intact extracellular region complex of Sema3A, PlexinA4 and Neuropilin 1 (Nrp1) at 3.7 Å resolution. The structure shows a large symmetric 2:2:2 assembly in which each subunit makes multiple interactions with others. The two PlexinA4 molecules in the complex do not interact directly, but their membrane proximal regions are close to each other and poised to promote the formation of the intracellular active dimer for signaling. The structure reveals a previously unknown interface between the a2b1b2 module in Nrp1 and the Sema domain of Sema3A. This interaction places the a2b1b2 module at the top of the complex, far away from the plasma membrane where the transmembrane regions of Nrp1 and PlexinA4 embed. As a result, the region following the a2b1b2 module in Nrp1 must span a large distance to allow the connection to the transmembrane region, suggesting an essential role for the long non-conserved linkers and the MAM domain in neuropilin in the semaphorin/plexin/neuropilin complex.

Indexed as

AnimalsChlorocebus aethiopsCOS CellsCryoelectron MicroscopyHEK293 CellsHumansMutationNerve Tissue ProteinsNeuropilin-1Protein BindingProtein DomainsProtein MultimerizationReceptors, Cell SurfaceRecombinant ProteinsSemaphorin-3ANerve Tissue ProteinsNeuropilin-1Plxna4 protein, mouseReceptors, Cell SurfaceRecombinant ProteinsSema3a protein, mouseSemaphorin-3A

Identifiers

PMID34039996
PMCPMC8155012
OpenAlexW3165189984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.